(1) Based on data and experience, develop list of otologic conditions to be targeted in the next 5 to 10 years. Include rationale.
|
|||||
Disease/Disorder/ Condition/Target |
PH Significance e.g., high prevalence, severe dz, limited tx options | Treatment Options e.g., none, ineffective, low benefit/risk ratio | Disease Severity e.g., dire consequences, dire disabilities, compromised QOL | Evidence Base e.g., none, some, limited | Stage of readiness for research involving humans |
Meniere's disease | Very high |
Unknown efficacy; |
Very debilitating in many people, compromised QOL. | Very limited |
Areas that are ready immediately: |
Age-related vestibular dysfunction |
Likely to be very high; contribution to falls in the elderly which have enormous mortality and economic impact |
Physical therapy, possible Vestibular Implant |
Likely to be very high |
Very limited; some studies that do demonstrate loss of hair cells and Scarpa’s ganglion cells with age; also studies that show decline in VOR with age |
Areas that are ready immediately: |
Migraine and vestibular dysfunction | Very high |
Unknown and/or limited efficacy |
Can be very severe and debilitating |
Very limited; genetics of some forms of migraine are known but relationship to vestibular symptoms is unknown |
Areas that are ready immediately: |
Incomplete compensation for vestibular hypofunction | Very high |
Unknown and/or |
Can be very severe |
Very limited; |
Areas that are ready immediately: |
Superior semicircular canal dehiscence | Prevalence is currently unknown; has relevance to understanding other disorders of the ear | Surgical repair; indications are being determined and outcomes monitored | Can be very disabling |
Physiological evidence of effects of dehiscence on vestibular function is strong; Underling cause is unknown |
Areas that are ready immediately: |
Autoimmune inner ear disease – vestibular dysfunction | Prevalence relatively low but impact on understanding other disorders of the ear is high | Efficacy of steroids has been established; other treatments still in investigational status | Can be very disabling | Evidence exists for autoimmune etiology; underlying cause is unknown |
Areas that are ready immediately: |
(2) For each target otologic condition, categorize the current state of knowledge regarding the condition and its interventions(if any) and the stage of research necessary for full development of the intervention.
|
|||||
Disease/Disorder/ Condition/Target |
Understanding of Dz/Disorder/Condition e.g., natural hx, treatment altering natural course | Understanding of patho-physiology | Is there a therapeutic target | Describe intervention: any modality e.g., surgery, drug, device, drug, behavior | Stage of development of intervention e.g., basic understanding/early translation, preclinical, clinical, definitive clinical trials, late translation |
Meniere’s disease | Incomplete – natural history is variable and needs to be more carefully studied |
Incomplete – approach that involves identification of candidate genes and studies of vestibular effects of knockouts of these genes in mice may be useful |
Not clear at present time | Staged approach to treatment:
|
Basic understanding |
Age-related vestibular dysfunction |
Incomplete – interactions of peripheral and central disorders is inadequate |
Incomplete – need to integrate approaches to studies of balance function |
Yes. e.g., Loss of vestibular function due to hair cell and ganglion cell death |
Regeneration medicine |
Basic understanding |
Migraine and vestibular dysfunction | Incomplete |
Very incomplete |
Not at present |
Basic understanding |
|
Incomplete compensation for vestibular hypofunction |
Different disorders result in vestibular hypofunction |
Incomplete |
Not at present |
Regeneration Vestibular implant |
Basic understanding of |
Superior semicircular canal dehiscence | Effects of dehiscence on vestibular function have been described | Cause of dehiscence and thinning is incomplete | Not at present |
|
Diagnostic testing Gene association studies |
Autoimmune inner ear disease – vestibular dysfunction | Natural history has been described for hearing loss; effects on vestibular function are unclear | Pathophysiology is not understood at level of immunologic dysfunction or hair cell/afferent disorder | Not at present |
Regeneration Vestibular implant |
Diagnostic testing Gene association studies |
Common Themes:
- Need to improve vestibular diagnostic tests:
– VEMPs
– Imaging (MRI – utility in Meniere’s, vestibular neuritis)
– Evaluation of VOR in response to rapid head movements
– Evaluation of otolith function
– Utility of these tests in longitudinal studies - Need better understanding of epidemiology across all vestibular pathologies.
- Need for gene association studies for many vestibular pathologies.
- Need for validated outcome measures in dizziness and balance disorders. Something analogous to Stage 1 behavioral study. It would be appropriate for these validated outcome measures to be developed before large-scale clinical trials.
Possible consideration:
Establish a Meniere’s disease ‘registry’ which involves multiple centers with agreed upon criteria for assessment of symptoms, stage of the disease, vestibular function, auditory function, and follow-up. Gene association studies to be performed on patients who enter the study. This registry and the centers involved will enable us to study the natural history of Meniere’s disease. We recommend beginning with a group of established centers with recognized expertise in Meniere’s disease. As a part of the development of this registry, standardized criteria will be developed by investigator’s participating in the registry for diagnosis, evaluation, and follow-up. This registry will then serve as the basis for future therapeutic intervention trials. This registry could, in the future, be opened for enrollment of patients by any practitioner who treats patients with Meniere’s disease.